Eye Infections Treatment Market: By Type of Infection By Medication, By Dosage Form, By Distribution Channel, Geography

Eye Infections Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type of Infection (Conjunctivitis, Blepharitis, Keratitis, Vitritis, Dry Eye, Chorioretinitis and Neuroretinitis) By Medication (Corticosteroids, Quinolone Antibiotics, Macrolide Antibiotics, Tetracycline Antibiotics, Polyene Antifungals, Aminoglycoside Antibiotics, Others), By Dosage Form (Gels and Cream, Eye drops, Tablets and Capsules), By Distribution Channel (Ophthalmology Clinics, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region

Eye Infections Treatment Market size was valued at US$ 7.2 billion in 2023 and is poised to grow at a CAGR of 3.6% from 2024-2030. The global market provides a detailed overview and that can be segmented by type of infection, by medication, by Dosage form, and by distribution channel. By type of infection, the market growth has been segmented into Conjunctivitis, Blepharitis, Keratitis, Vitritis, Dry Eye, Chorioretinitis and Neuroretinitis. The Conjunctivitis segment is likely to be the largest and fastest-growing segment in terms of type of infection. The rise of this segment is mainly due to a rise in the prevalence of such infections. The segment is expected to witness growth in the forecast period due to the growing number of product launches to cure allergic conjunctivitis. It usually happens in people having seasonal allergies. Based on Medication, the market is segmented into Corticosteroids, Quinolone Antibiotics, Macrolide Antibiotics, Tetracycline Antibiotics, Polyene Antifungals, Aminoglycoside Antibiotics, and Others. Among these, the Tetracycline Antibiotics medication segment is expected to have a significantly growing market during the forecast period 2022-2028. Based on the Dosage form, the market is segmented into Gels and Cream, Eye drops, Tablets and Capsules. The Eye drops segment is expected to have a significant share in 2021. Based on the distribution channel, the market is segmented into Ophthalmology Clinics, Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The hospital pharmacies segment is expected to have a significant share in 2021. The rise of this segment is mainly because of the surge in patient appointments to hospitals for regular eye check-ups and others issues. Besides, the online pharmacies segment is expected to arise as the fastest-growing segment in the eye infection treatment market share

Eye Infections Treatment Market Key Developments

Eyevance Pharmaceuticals announced its partnership with Hikma Pharmaceuticals PLC for the promotion of ZERVIATE, which is used to treat ocular itching concerned with allergic conjunctivitis.

Download Free Sample

Eye Infections Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

3.6%

Largest Market

North America

Fastest Growing Market

Europe

Eye Infections Treatment Market Dynamics

Technological Advancements in Treatment and Diagnosis for Eye Infections is anticipated to propel the market growth over the forecast years. Moreover, the growing incidence of multiple vision conditions worldwide is burgeoning the market growth over the forecast years.

North-America Got Significant Share

Eye Infections Treatment Market Regional Analysis

North America is a top revenue generator in global market that is mainly due to some factors like new FDA approvals, aggressive strategies by pharmaceutical companies, increasing investment in R&D as well as clinical trials. The European market is the second largest market for Market. Increasing prevalence and growing awareness of conjunctivitis and its treatments are leading the growth of Asia Pacific Market. The Middle East and Africa market is expected to have limited growth because of lack of traditional healthcare practices and slow adoption of new products and therapies.

Latin America

Europe

Asia Pacific

Middle East

North America

Eye Infections Treatment Market Segmentation Analysis

Report Benchmarks	Details
Report Study Period	2024-2030
Market Size in 2023	US$ 7.2 billion
Market CAGR	3.6%
By Type of Infection	Conjunctivitis Blepharitis Keratitis Vitritis Dry eye Chorioretinitis Neuroretinitis
By Medication	Corticosteroids Quinolone Antibiotics Macrolide Antibiotics Tetracycline Antibiotics Polyene Antifungals Aminoglycoside Antibiotics Others
By Dosage Form	Gels and Cream Eye drops Tablets and Capsules
By Region	North America Europe Asia Pacific Latin America Middle East Africa

Key Features of the Report

The report provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startups details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global eye infections treatment market size was valued at US$ 7.2 billion in 2023 and is poised to grow at a CAGR of 3.6% from 2024-2030.

In January 2022, NovaBay Pharmaceuticals launched new eye drops to treat dry eye symptoms.

High severe effects of drugs and expiry of the patent

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary

2. Global Eye Infections Treatment Market Introduction

2.1.Global Eye Infections Treatment Market - Taxonomy

2.2.Global Eye Infections Treatment Market - Definitions

2.2.1.Type of Infection

2.2.2.Medication

2.2.3.Dosage Form

2.2.4.Region

3. Global Eye Infections Treatment Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Product Landscape

3.6. New Product Launches

3.7. Impact of COVID 19 on Market

4.Global Eye Infections Treatment Market Analysis, 2019-2023 and Forecast 2024-2030

4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Eye Infections Treatment Market By Type of Infection, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

5.1. Conjunctivitis

5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Blepharitis

5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Keratitis

5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

5.4. Vitritis

5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.4.3. Market Opportunity Analysis

5.5. Dry eye

5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.5.3. Market Opportunity Analysis

5.6. Chorioretinitis

5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.6.3. Market Opportunity Analysis

5.7. Neuroretinitis

5.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.7.3. Market Opportunity Analysis

6. Global Eye Infections Treatment Market By Medication, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

6.1. Corticosteroids

6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Quinolone Antibiotics

6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Macrolide Antibiotics

6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Tetracycline Antibiotics

6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

6.5. Polyene Antifungals

6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.5.3. Market Opportunity Analysis

6.6. Aminoglycoside Antibiotics

6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.6.3. Market Opportunity Analysis

6.7. Others

6.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.7.3. Market Opportunity Analysis

7. Global Eye Infections Treatment Market By Dosage Form, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

7.1. Gels and Cream

7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Eye drops

7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Tablets and Capsules

7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

8. Global Eye Infections Treatment Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

8.1. North America

8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Asia Pacific (APAC)

8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Middle East and Africa (MEA)

8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. Latin America

8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

9. North America Eye Infections Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

9.1. Type of Infection Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.1.1.Conjunctivitis

9.1.2.Blepharitis

9.1.3.Keratitis

9.1.4.Vitritis

9.1.5.Dry eye

9.1.6.Chorioretinitis

9.1.7.Neuroretinitis

9.2. Medication Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.2.1.Corticosteroids

9.2.2.Quinolone Antibiotics

9.2.3.Macrolide Antibiotics

9.2.4.Tetracycline Antibiotics

9.2.5.Polyene Antifungals

9.2.6.Aminoglycoside Antibiotics

9.2.7.Others

9.3. Dosage Form Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.3.1.Gels and Cream

9.3.2.Eye drops

9.3.3.Tablets and Capsules

9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.4.1.United States of America (USA)

9.4.2.Canada

10. Europe Eye Infections Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

10.1. Type of Infection Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.1.1.Conjunctivitis

10.1.2.Blepharitis

10.1.3.Keratitis

10.1.4.Vitritis

10.1.5.Dry eye

10.1.6.Chorioretinitis

10.1.7.Neuroretinitis

10.2. Medication Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.2.1.Corticosteroids

10.2.2.Quinolone Antibiotics

10.2.3.Macrolide Antibiotics

10.2.4.Tetracycline Antibiotics

10.2.5.Polyene Antifungals

10.2.6.Aminoglycoside Antibiotics

10.2.7.Others

10.3. Dosage Form Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.3.1.Gels and Cream

10.3.2.Eye drops

10.3.3.Tablets and Capsules

10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.4.1.Germany

10.4.2.France

10.4.3.Italy

10.4.4.United Kingdom (UK)

10.4.5.Spain

10.4.6.Rest of EU

10.4.7.

11. Asia Pacific (APAC) Eye Infections Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

11.1. Type of Infection Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.1.1.Conjunctivitis

11.1.2.Blepharitis

11.1.3.Keratitis

11.1.4.Vitritis

11.1.5.Dry eye

11.1.6.Chorioretinitis

11.1.7.Neuroretinitis

11.2. Medication Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.2.1.Corticosteroids

11.2.2.Quinolone Antibiotics

11.2.3.Macrolide Antibiotics

11.2.4.Tetracycline Antibiotics

11.2.5.Polyene Antifungals

11.2.6.Aminoglycoside Antibiotics

11.2.7.Others

11.3. Dosage Form Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.3.1.Gels and Cream

11.3.2.Eye drops

11.3.3.Tablets and Capsules

11.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.4.1.China

11.4.2.India

11.4.3.Australia and New Zealand (ANZ)

11.4.4.Japan

11.4.5.Rest of APAC

12. Middle East and Africa (MEA) Eye Infections Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

12.1. Type of Infection Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.1.1.Conjunctivitis

12.1.2.Blepharitis

12.1.3.Keratitis

12.1.4.Vitritis

12.1.5.Dry eye

12.1.6.Chorioretinitis

12.1.7.Neuroretinitis

12.2. Medication Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.2.1.Corticosteroids

12.2.2.Quinolone Antibiotics

12.2.3.Macrolide Antibiotics

12.2.4.Tetracycline Antibiotics

12.2.5.Polyene Antifungals

12.2.6.Aminoglycoside Antibiotics

12.2.7.Others

12.3. Dosage Form Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.3.1.Gels and Cream

12.3.2.Eye drops

12.3.3.Tablets and Capsules

12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.4.1.GCC Countries

12.4.2.South Africa

12.4.3.Rest of MEA

13. Latin America Eye Infections Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

13.1. Type of Infection Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.1.1.Conjunctivitis

13.1.2.Blepharitis

13.1.3.Keratitis

13.1.4.Vitritis

13.1.5.Dry eye

13.1.6.Chorioretinitis

13.1.7.Neuroretinitis

13.2. Medication Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.2.1.Corticosteroids

13.2.2.Quinolone Antibiotics

13.2.3.Macrolide Antibiotics

13.2.4.Tetracycline Antibiotics

13.2.5.Polyene Antifungals

13.2.6.Aminoglycoside Antibiotics

13.2.7.Others

13.3. Dosage Form Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.3.1.Gels and Cream

13.3.2.Eye drops

13.3.3.Tablets and Capsules

13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.4.1.Brazil

13.4.2.Mexico

13.4.3.Rest of LA

14. Competition Landscape

14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis)

14.2.1.Boehringer Ingelheim GmbH (Germany)

14.2.2.Allergan Inc. (Ireland)

14.2.3.Sanofi-Aventis (France)

14.2.4.Novartis AG (Switzerland)

14.2.5.Bausch & Lomb Inc. (USA)

14.2.6.CIBA Vision Ophthalmics (USA)

14.2.7.Pfizer Inc. (USA)

14.2.8.Merck & Co., Inc. (USA)

15. Research Methodology

16. Appendix and Abbreviations

Key Market Players

Boehringer Ingelheim GmbH (Germany)
Allergan Inc. (Ireland)
Sanofi-Aventis (France)
Novartis AG (Switzerland)
Bausch & Lomb Inc. (USA)
CIBA Vision Ophthalmics (USA)
Pfizer Inc. (USA)
Merck & Co., Inc. (USA)
Santen Pharmaceuticals Co. Ltd.(Japan)

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market